Regulatory writing for rare disease: An interview with Kelley Hill

Sarah Milner

Volume 34, Issue 1 - Rare Diseases

Regulatory writing for rare disease: An interview with Kelley Hill

Author: Sarah Milner

Abstract

Over her 40-year career, Kelley Hill has become regarded as an industry expert in strategic, high-quality, and impactful regulatory writing, especially in the rare disease space. Now enjoying a slower pace of life having retired in 2023, she has led highly successful writing departments in pharma, including at Shire, Certara, and, most recently, Alexion, and contract research organisations. Medical Writing guest editor Sarah Milner asked her about her experience as a writer in rare disease over the years.

Medical Writing. 2025;34(1):22–23. https://doi.org/10.56012/gfym3039

Download the full article

Volume 34, Issue 1 - Rare Diseases

Regulatory writing for rare disease: An interview with Kelley Hill

Author: Sarah Milner

Abstract

Search

Articles

Links

Editoral Board